Luis Moral

1.2k total citations
30 papers, 689 citations indexed

About

Luis Moral is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Luis Moral has authored 30 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 9 papers in Epidemiology. Recurrent topics in Luis Moral's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (8 papers) and Drug-Induced Adverse Reactions (6 papers). Luis Moral is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (8 papers) and Drug-Induced Adverse Reactions (6 papers). Luis Moral collaborates with scholars based in Spain, Italy and Switzerland. Luis Moral's co-authors include Rosaria Scozzari, Célia Bádenas, Antonio Torroni, Anna Barceló, Xavier Estivill, Massimo Zeviani, Nancy Govea, Manuel Moya Benavent, Jean‐Christoph Caubet and María Jesús Fuentes Rebollo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Human Genetics and Transactions of the Royal Society of Tropical Medicine and Hygiene.

In The Last Decade

Luis Moral

23 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Moral Spain 8 302 224 90 88 87 30 689
S. Ernstson Sweden 12 49 0.2× 137 0.6× 24 0.3× 24 0.3× 45 0.5× 24 346
Mark D. Rizzi United States 12 81 0.3× 100 0.4× 17 0.2× 16 0.2× 35 0.4× 30 498
H. Stupp Germany 11 81 0.3× 123 0.5× 11 0.1× 42 0.5× 76 0.9× 34 553
Halit Oğuz Türkiye 14 53 0.2× 11 0.0× 288 3.2× 20 0.2× 17 0.2× 65 716
Vicente Díaz‐Sánchez Mexico 17 157 0.5× 86 0.4× 125 1.4× 36 0.4× 1 0.0× 36 775
Jürgen Homann Germany 14 136 0.5× 12 0.1× 15 0.2× 65 0.7× 5 0.1× 36 649
J. M. Graham United Kingdom 13 196 0.6× 38 0.2× 25 0.3× 11 0.1× 14 0.2× 26 476
Flora Reverchon France 9 96 0.3× 8 0.0× 62 0.7× 20 0.2× 65 0.7× 15 500
Juan Xu China 12 171 0.6× 12 0.1× 32 0.4× 7 0.1× 10 0.1× 29 411
Carlos Hiroji Hiroki Brazil 11 175 0.6× 3 0.0× 73 0.8× 19 0.2× 75 0.9× 15 567

Countries citing papers authored by Luis Moral

Since Specialization
Citations

This map shows the geographic impact of Luis Moral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Moral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Moral more than expected).

Fields of papers citing papers by Luis Moral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Moral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Moral. The network helps show where Luis Moral may publish in the future.

Co-authorship network of co-authors of Luis Moral

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Moral. A scholar is included among the top collaborators of Luis Moral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Moral. Luis Moral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuyucu, Semanur, Natalia Blanca‐López, Jean‐Christoph Caubet, et al.. (2025). Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper. Pediatric Allergy and Immunology. 36(7). e70103–e70103. 1 indexed citations
2.
Muñoz, A, et al.. (2025). Drug-induced fixed urticaria because of hypersensitivity to non steroidal anti-inflammatory drugs. Allergologia et Immunopathologia. 53(6). 157–161.
3.
Moral, Luis, et al.. (2024). Allergic contact dermatitis to chlorhexidine in children. Allergologia et Immunopathologia. 52(6). 33–39.
4.
Moreno‐Galarraga, Laura, et al.. (2024). Inhaled medications and inhalation chambers for childhood asthma. Spanish network of working groups on asthma in pediatrics (REGAP). SHILAP Revista de lepidopterología. 100(2). 123–131.
5.
Moral, Luis, et al.. (2022). Positive drug provocation with beta-lactam antibiotics in children: A single test may not be enough. Allergologia et Immunopathologia. 50(5). 148–152. 5 indexed citations
6.
Moral, Luis, et al.. (2022). Epidemiology of pediatric parapneumonic pleural effusion during 13-valent pneumococcal conjugate vaccine implementation. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(7). 414–419.
7.
Moral, Luis, et al.. (2022). Drug reexposure in children with severe mucocutaneous reactions. Allergologia et Immunopathologia. 50(1). 104–107. 2 indexed citations
8.
Moral, Luis, et al.. (2021). Pediatric asthma: The REGAP consensus. SHILAP Revista de lepidopterología. 95(2). 125.e1–125.e11. 4 indexed citations
9.
Moral, Luis, et al.. (2021). Population-Based Cohort of Children With Parapneumonic Effusion and Empyema Managed With Low Rates of Pleural Drainage. Frontiers in Pediatrics. 9. 621943–621943. 3 indexed citations
10.
Moral, Luis & Jean‐Christoph Caubet. (2017). Oral challenge without skin tests in children with non‐severe beta‐lactam hypersensitivity: Time to change the paradigm?. Pediatric Allergy and Immunology. 28(8). 724–727. 38 indexed citations
11.
12.
Moral, Luis, et al.. (2015). Derrame paraneumónico complicado: análisis de 2 cohortes consecutivas tratadas con distinto criterio. Anales de Pediatría. 84(1). 46–53. 5 indexed citations
13.
Moral, Luis, et al.. (2013). Asociación entre la exposición a paracetamol y el asma: estado de la cuestión y recomendaciones prácticas. Anales de Pediatría. 79(3). 188.e1–188.e5. 1 indexed citations
14.
Moral, Luis, et al.. (2012). Asthma and paracetamol: Could we really know what happens between them?. Allergologia et Immunopathologia. 41(4). 261–264. 8 indexed citations
15.
Moral, Luis, et al.. (2011). Burden of Severe 2009 Pandemic Influenza A (H1N1) Infection in Children in Southeast Spain. Enfermedades Infecciosas y Microbiología Clínica. 29(7). 497–501. 4 indexed citations
16.
Moral, Luis, et al.. (2011). Short protocol for the study of paediatric patients with suspected betalactam antibiotic hypersensitivity and low risk criteria. Allergologia et Immunopathologia. 39(6). 337–341. 36 indexed citations
17.
Moral, Luis, et al.. (2002). A leishmanin skin test survey in the human population of l'Alacantí Region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe. Transactions of the Royal Society of Tropical Medicine and Hygiene. 96(2). 129–132. 69 indexed citations
18.
Moral, Luis & Manuel Moya Benavent. (1998). Qué ha sido de la leishmaniasis. Anales de Pediatría. 49(1). 5–10. 2 indexed citations
19.
Estivill, Xavier, Nancy Govea, Anna Barceló, et al.. (1998). Familial Progressive Sensorineural Deafness Is Mainly Due to the mtDNA A1555G Mutation and Is Enhanced by Treatment with Aminoglycosides. The American Journal of Human Genetics. 62(1). 27–35. 417 indexed citations
20.
Moral, Luis, et al.. (1992). Unsuspected rheumatic heart underlying group B streptococcal endocarditis at the age of 20 months. European Journal of Pediatrics. 151(10). 745–747. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Ernstson Breakdown of academic impact, for papers by Mark D. Rizzi Breakdown of academic impact, for papers by H. Stupp Breakdown of academic impact, for papers by Halit Oğuz Breakdown of academic impact, for papers by Vicente Díaz‐Sánchez Breakdown of academic impact, for papers by Jürgen Homann Breakdown of academic impact, for papers by J. M. Graham Breakdown of academic impact, for papers by Flora Reverchon Breakdown of academic impact, for papers by Juan Xu Breakdown of academic impact, for papers by Carlos Hiroji Hiroki
Rankless by CCL
2026